Compounds > olomoucine

olomoucine and Carcinoma, Non-Small Cell Lung

olomoucine has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuijpers, HJ; Ramaekers, FC; Reutelingsperger, CP; Schutte, B; van Engeland, M1
Henfling, ME; Meijer, L; Nieland, L; Ramaekers, FC; Schutte, B; van Engeland, M1

Other Studies

2 other study(ies) available for olomoucine and Carcinoma, Non-Small Cell Lung

ArticleYear
Plasma membrane alterations and cytoskeletal changes in apoptosis.
    Experimental cell research, 1997, Sep-15, Volume: 235, Issue:2

    Topics: Actins; Annexin A5; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Membrane; Chromatin; Cytoskeleton; Ethylmaleimide; Humans; Keratins; Kinetin; Lung Neoplasms; Neuroblastoma; Phosphatidylserines; Purines; Roscovitine; Tetradecanoylphorbol Acetate; Tubulin; Tumor Cells, Cultured; Vimentin

1997
The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
    Experimental cell research, 1997, Oct-10, Volume: 236, Issue:1

    Topics: Antimetabolites; Apoptosis; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; CDC2 Protein Kinase; Cell Cycle; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; G2 Phase; Humans; Kinetin; Lung Neoplasms; Mitosis; Neuroblastoma; Purines; Roscovitine; S Phase; Tumor Cells, Cultured

1997